CD4 and neoplasm: We found that inhibition of B7-H3 in mouse models with high mTORC1 activity inhibits tumor growth, associated with increased infiltration of cytotoxic CD38 and CD39-double-positive CD4+ T cells and increased IFN-γ responses and MHC-II expression.